Anti-Nuclear Antibody (ANA) ELISA Kits

The protein encoded by ANA is a member of the BTG/Tob family.

list all ELISA KIts Gen GeneID UniProt
ANA 10950 Q14201
ANA    
ANA    
Direkt bei antikoerper-online bestellen
  • +1 877 302 8632
  • +1 888 205 9894 (toll-free)
  • Online bestellen
  • orders@antikoerper-online.de

Top Anti-Nuclear Antibody ELISA Kits auf antikoerper-online.de

Showing 10 out of 23 products:

Katalog Nr. Reaktivität Sensitivität Bereich Bilder Menge Anbieter Lieferzeit Preis Details
Meerschweinchen 1.0 ng/mL 5.0-100 ng/mL   96 Tests Anmelden zum Anzeigen 15 bis 18 Tage
$707.14
Details
Kaninchen 1.0 ng/mL 5.0-100 ng/mL   96 Tests Anmelden zum Anzeigen 15 bis 18 Tage
$707.14
Details
Ratte 1.0 ng/mL 5-100 ng/mL   96 Tests Anmelden zum Anzeigen 15 bis 18 Tage
$707.14
Details
Maus 1.0 ng/mL 5.0-100 ng/mL   96 Tests Anmelden zum Anzeigen 15 bis 18 Tage
$707.14
Details
Human 1.0 ng/mL 5-100 ng/mL   96 Tests Anmelden zum Anzeigen 15 bis 18 Tage
$707.14
Details
Affe 1.0 ng/mL 5-100 ng/mL   96 Tests Anmelden zum Anzeigen 15 bis 18 Tage
$707.14
Details
Schwein
  96 Tests Anmelden zum Anzeigen 15 bis 18 Tage
$707.14
Details
Hund 1.0 ng/mL 5.0-100 ng/mL   96 Tests Anmelden zum Anzeigen 15 bis 18 Tage
$707.14
Details
Huhn
  96 Tests Anmelden zum Anzeigen 15 bis 18 Tage
$707.14
Details
Schaf
  96 Tests Anmelden zum Anzeigen 15 bis 18 Tage
$707.14
Details

Weitere ELISA Kits für Anti-Nuclear Antibody Interaktionspartner

Human Anti-Nuclear Antibody (ANA) Interaktionspartner

  1. Inhibition of miR-93-5p may have blocked HPV-positive cervical cancer development by targeting of BTG3.

  2. BTG3 overexpression inhibited cell growth, induced cell cycle arrest and suppressed the metastasis of SW480 cells via the Wnt/beta-catenin signaling pathway. BTG3 may be considered as a therapeutic target in CRC treatment.

  3. Data show that miR-139 can repress the proliferation of hepatocellular carcinoma (HCC) cells via directly inhibiting the expression of ANA protein, human Add B-cell translocation gene 3 protein (BTG3).

  4. Taken together, the results of our study suggest that BTG3 overexpression could inhibit cell proliferation and invasion and promotes cell apoptosis in EOC cell, possibly by regulating the AKT/GSK3beta/beta-catenin signaling pathway

  5. BTG3 expression might contribute to CRC carcinogenesis. BTG3 knockdown might strengthen the aggressive colorectal cancer behavior.

  6. BTG3 is a direct downstream target of miR-106b-5p.

  7. BTG3 overexpression inhibited tumor growth of SW620 cells by suppressing proliferation and inducing apoptosis. It was suggested that down-regulated BTG3 expression might be considered as a marker for colorectal carcinogenesis.

  8. ANA and ASMA evaluation in patients with liver transplantation and no history of autoimmune disease has no clinical relevance, since it varies in time and is not related to any risk factors or liver injury. Routine autoimmunity evaluation should be avoided.

  9. BTG3 overexpression might reverse the aggressive phenotypes and be employed as a potential target for gene therapy of gastric cancer.

  10. The suppressed migration and invasion abilities found in BTG3-overexpressing esophageal adenocarcinoma cells. Our findings suggested that BTG3 is suppressor in the progression of esophageal adenocarcinoma

  11. BTG3 binds and suppresses AKT, a kinase frequently deregulated in cancers.

  12. Down-regulation of BTG3 promotes cell proliferation, migration and invasion in gastric cancer.

  13. BTG3 protein expression may be considered as a good marker to indicate the favorable prognosis of epithelial ovarian carcinoma.

  14. These results disclosed an important role of BTG3 in lung tumorigenesis.

  15. BTG3-dependent CHK1 ubiquitination contributes to its chromatin localization and activation and a defect in this regulation may increase genome instability and promote tumorigenesis

  16. loss of BTG3 in normal cells induced cellular senescence, which was correlated with enhanced ERK-AP1 signaling and elevated expression of the histone H3K27me3 demethylase JMJD3/KDM6B

  17. by disrupting the DNA binding activity of E2F1, BTG3 participates in the regulation of E2F1 target gene expression. Therefore, our studies have revealed a previously unidentified pathway through which the activity of E2F1 may be guarded by activated p53.

  18. These data support the hypothesis that BTG3 may act to suppress tumorigenesis and that hypermethylation is an important mechanism for inactivation of BTG3 and perhaps other tumor suppressor genes.

  19. BTG3 is epigenetically silenced in renal cancer

Anti-Nuclear Antibody (ANA) Antigen-Profil

Beschreibung des Gens

The protein encoded by this gene is a member of the BTG/Tob family. This family has structurally related proteins that appear to have antiproliferative properties. This encoded protein might play a role in neurogenesis in the central nervous system. Two transcript variants encoding different isoforms have been found for this gene.

Genbezeichner und Symbole assoziert mit Anti-Nuclear Antibody (ANA) ELISA Kits

  • BTG anti-proliferation factor 3 (BTG3) Antikörper
  • ANA Antikörper
  • TOB5 Antikörper
  • TOB55 Antikörper
  • TOFA Antikörper

Bezeichner auf Proteinebene für Anti-Nuclear Antibody (ANA) ELISA Kits

B-cell translocation gene 3 , abundant in neuroepithelium area protein , protein BTG3 , protein Tob5

GENE ID SPEZIES
10950 Homo sapiens
Ausgewählte Anbieter für Anti-Nuclear Antibody (ANA) ELISA Kits
Haben Sie etwas anderes gesucht?